Skip to content
2000
Volume 20, Issue 2
  • ISSN: 1573-3947
  • E-ISSN: 1875-6301

Abstract

Gliomas are a group of brain cancers with various clinical and biological features, and they are mostly malignant. Progressions in therapy approaches, comprising radiotherapy, chemotherapy, and surgery, have not been so considerable in the prognosis of glioma cases. Recently, long noncoding RNAs (lncRNAs) have been found with putative regulatory roles in gene expression, epigenetic regulation, neurogenesis, cell cycle, and cellular transportation. The lncRNA Metastasis Associated Lung Adenocarcinoma Transcript 1 (MALAT1) is frequently reported to be associated with multiple disorders, such as various types of cancers. Upregulation of MALAT1 is detected in different tumours, including glioma, and functional analyses reveal it affects malignant features of cancer cells like proliferation, migration, invasion and apoptosis. MALAT1 impacts those features by modulating various epigenetic histones, hormones, growth factors, and transcription factors. Therefore, this lncRNA can be regarded as a potent therapeutic target for glioma. In this review, we summarized the functional roles of MALAT1 in glioma.

Loading

Article metrics loading...

/content/journals/cctr/10.2174/1573394719666230720164009
2024-03-01
2025-05-22
Loading full text...

Full text loading...

/content/journals/cctr/10.2174/1573394719666230720164009
Loading

  • Article Type:
    Review Article
Keyword(s): biomarker; cell signalling; Glioma; LncRNAs; MALAT1; pathogenesis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test